Super-resolution ultrasound for liver tumors
Part of Cancer, Digestive system clinical trials.
This study tests a new, more detailed ultrasound technique to better see liver tumors. It may help doctors understand your tumor better without extra procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been newly diagnosed with a liver tumor, such as liver cancer, a tumor that spread from elsewhere, or a non-cancerous growth.
- You are scheduled to have a contrast-enhanced ultrasound as part of your regular care.
- You are willing to discuss the study with your doctor and sign a consent form.
- You have not had a biopsy or other treatment for your liver tumor before this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
This study uses advanced imaging (MRI and contrast-enhanced ultrasound) with computer technology to help doctors decide the best treatment for early-stage liver cancer. It aims to improve outcomes for patients who undergo surgery or microwave ablation.
This study compares two imaging methods, ultrasound and MRI, to see which is better at finding liver cancer early in people who are at high risk. Early detection could lead to more effective treatment and better outcomes.
This trial tests a focused ultrasound therapy called histotripsy to destroy liver tumors that are close to major blood vessels and cannot be surgically removed. The goal is to see if this non-invasive approach is safe and effective for tumors that are otherwise hard to treat.
This study tests whether a special 3D ultrasound scan (using contrast) can help support decisions for people with colorectal cancer that has spread to the liver. If you have planned new cancer treatment, the scan may add information to help doctors guide care.
This study is testing a new way to use ultrasound to help treat colorectal cancer that has spread to the liver. It may help doctors see how tumors respond to treatment.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.